Responses
Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
FRI0155 Fifty Percent of Patients Who Tapered TNF-Blockers while in Stable Remission Are Able To Maintain A Tapered Regimen at 3 Year: Long Term Follow-Up Extension of The Strass Trial
Compose a Response to This Article
Other responses
No responses have been published for this article.